966 related articles for article (PubMed ID: 9472608)
21. Physical and functional interaction between the Y-box binding protein YB-1 and human polyomavirus JC virus large T antigen.
Safak M; Gallia GL; Ansari SA; Khalili K
J Virol; 1999 Dec; 73(12):10146-57. PubMed ID: 10559330
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of the basal-level activity of HIV-1 long terminal repeat by HIV-1 nucleocapsid protein.
Zhang JL; Sharma PL; Crumpacker CS
Virology; 2000 Mar; 268(2):251-63. PubMed ID: 10704334
[TBL] [Abstract][Full Text] [Related]
23. Functional similarities between HIV-1 Tat and DNA sequence-specific transcriptional activators.
Madore SJ; Cullen BR
Virology; 1995 Feb; 206(2):1150-4. PubMed ID: 7856090
[TBL] [Abstract][Full Text] [Related]
24. Evidence that a cell cycle regulator, E2F1, down-regulates transcriptional activity of the human immunodeficiency virus type 1 promoter.
Kundu M; Srinivasan A; Pomerantz RJ; Khalili K
J Virol; 1995 Nov; 69(11):6940-6. PubMed ID: 7474112
[TBL] [Abstract][Full Text] [Related]
25. Identification of a cellular protein that binds to Tat-responsive element of TGF beta-1 promoter in glial cells.
Thatikunta P; Sawaya BE; Denisova L; Cole C; Yusibova G; Johnson EM; Khalili K; Amini S
J Cell Biochem; 1997 Dec; 67(4):466-77. PubMed ID: 9383706
[TBL] [Abstract][Full Text] [Related]
26. The human immunodeficiency virus long terminal repeat includes a specialised initiator element which is required for Tat-responsive transcription.
Rittner K; Churcher MJ; Gait MJ; Karn J
J Mol Biol; 1995 May; 248(3):562-80. PubMed ID: 7752225
[TBL] [Abstract][Full Text] [Related]
27. Activation of the human immunodeficiency virus type 1 long terminal repeat by transforming mutants of human p53.
Subler MA; Martin DW; Deb S
J Virol; 1994 Jan; 68(1):103-10. PubMed ID: 8254719
[TBL] [Abstract][Full Text] [Related]
28. Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1.
Majello B; De Luca P; Hagen G; Suske G; Lania L
Nucleic Acids Res; 1994 Nov; 22(23):4914-21. PubMed ID: 7800480
[TBL] [Abstract][Full Text] [Related]
29. HIV-1 Tat protein can transactivate a heterologous TATAA element independent of viral promoter sequences and the trans-activation response element.
Roebuck KA; Rabbi MF; Kagnoff MF
AIDS; 1997 Feb; 11(2):139-46. PubMed ID: 9030359
[TBL] [Abstract][Full Text] [Related]
30. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein.
Kamine J; Subramanian T; Chinnadurai G
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8510-4. PubMed ID: 1924310
[TBL] [Abstract][Full Text] [Related]
31. Cross-interaction between JC virus agnoprotein and human immunodeficiency virus type 1 (HIV-1) Tat modulates transcription of the HIV-1 long terminal repeat in glial cells.
Kaniowska D; Kaminski R; Amini S; Radhakrishnan S; Rappaport J; Johnson E; Khalili K; Del Valle L; Darbinyan A
J Virol; 2006 Sep; 80(18):9288-99. PubMed ID: 16940540
[TBL] [Abstract][Full Text] [Related]
32. The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter.
Gómez-Gonzalo M; Carretero M; Rullas J; Lara-Pezzi E; Aramburu J; Berkhout B; Alcamí J; López-Cabrera M
J Biol Chem; 2001 Sep; 276(38):35435-43. PubMed ID: 11457829
[TBL] [Abstract][Full Text] [Related]
33. Sp1 and related factors fail to interact with the NF-kappaB-proximal G/C box in the LTR of a replication competent, brain-derived strain of HIV-1 (YU-2).
Millhouse S; Krebs FC; Yao J; McAllister JJ; Conner J; Ross H; Wigdahl B
J Neurovirol; 1998 Jun; 4(3):312-23. PubMed ID: 9639074
[TBL] [Abstract][Full Text] [Related]
34. Steroidogenic factor 1 (SF-1) and SP1 are required for regulation of bovine CYP11A gene expression in bovine luteal cells and adrenal Y1 cells.
Liu Z; Simpson ER
Mol Endocrinol; 1997 Feb; 11(2):127-37. PubMed ID: 9013760
[TBL] [Abstract][Full Text] [Related]
35. Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2).
Burysek L; Yeow WS; Pitha PM
J Hum Virol; 1999; 2(1):19-32. PubMed ID: 10200596
[TBL] [Abstract][Full Text] [Related]
36. Human immunodeficiency virus type 1 Tat prevents dephosphorylation of Sp1 by TCF-4 in astrocytes.
Rossi A; Mukerjee R; Ferrante P; Khalili K; Amini S; Sawaya BE
J Gen Virol; 2006 Jun; 87(Pt 6):1613-1623. PubMed ID: 16690926
[TBL] [Abstract][Full Text] [Related]
37. Identification and characterization of a human herpesvirus 6 gene segment capable of transactivating the human immunodeficiency virus type 1 long terminal repeat in an Sp1 binding site-dependent manner.
Wang J; Jones C; Norcross M; Bohnlein E; Razzaque A
J Virol; 1994 Mar; 68(3):1706-13. PubMed ID: 8107231
[TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor.
Jeang KT; Chun R; Lin NH; Gatignol A; Glabe CG; Fan H
J Virol; 1993 Oct; 67(10):6224-33. PubMed ID: 7690421
[TBL] [Abstract][Full Text] [Related]
39. Activation of the human immunodeficiency virus type 1 long terminal repeat by BTEB, a GC box-binding transcription factor.
Imataka H; Mizuno A; Fujii-Kuriyama Y; Hayami M
AIDS Res Hum Retroviruses; 1993 Sep; 9(9):825-31. PubMed ID: 8257632
[TBL] [Abstract][Full Text] [Related]
40. Tumour metastasis suppressor, nm23-beta, inhibits gelatinase A transcription by interference with transactivator Y-box protein-1 (YB-1).
Cheng S; Alfonso-Jaume MA; Mertens PR; Lovett DH
Biochem J; 2002 Sep; 366(Pt 3):807-16. PubMed ID: 12010125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
